Stock & Company Details
AEON Biopharma Inc. $AEON
Price:
N/A
N/A
50M
$15M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.08
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
AEON technical indicators
Latest AEON Biopharma Inc. (AEON) indicator readings as of 2026-08-28.
AEON's 14-day RSI is 54.2, in neutral territory. At $0.31 it is trading 62.0% below its 200-day moving average of $0.83, and below its 50-day average of $0.39. Price sits near the upper Bollinger Band ($0.18 to $0.34). ADX reads 41.7, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
we are a nasdaq-listed special purpose acquisition company whose business purpose is to effect a merger or similar business combination with one or more businesses. our acquisition strategy is to identify and complete our initial business combination with a medical technology company in the healthcare industry. our sponsor team consists of chairman/ceo robert palmisano, president vikram malik, cfo oleg grodnensky and chief legal officer david meredith.
Finance Bot
Ask your questions
Start by typing a question below.
